Medicare Enrolled
Dr. Tarek Eldawy, M.D.
Hematology & Oncology · Oviedo, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Eldawy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eldawy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Eldawy
Dr. Tarek Eldawy is a hematology & oncology specialist in Oviedo, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Eldawy performed 11,781 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Eldawy received a total of $46,938 from 69 pharmaceutical and/or device companies across 448 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Eldawy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 26% volume in FL
$46,938 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗11,781
Medicare services
Top 26% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
8,100 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 1,560 | $19 | $51 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
576 | $73 | $135 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
539 | $49 | $112 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
229 | $8 | $9 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
213 | $8 | $29 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
132 | $11 | $69 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
68 | $63 | $182 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
56 | $1 | $6 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
52 | $20 | $42 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
48 | $49 | $189 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $111 | $258 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
36 | $96 | $264 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
31 | $71 | $193 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $123 | $335 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
26 | $102 | $352 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
23 | $29 | $156 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $133 | $534 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.4% high complexity
83.8% medium
15.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$46,938
Total received (2018-2024)
Avg $6,705/year across 7 years
Top 15% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
448
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,631
2023
$7,802
2022
$4,843
2021
$295
2020
$3,148
2019
$16,516
2018
$5,701
Payments by company (2024)
Ipsen Biopharmaceuticals, Inc
$2,436
Novartis Pharmaceuticals Corporation
$1,419
AstraZeneca Pharmaceuticals LP
$608
Celgene Corporation
$379
PFIZER INC.
$312
Eisai Inc.
$263
Merck Sharp & Dohme LLC
$239
Daiichi Sankyo Inc.
$212
Janssen Biotech, Inc.
$185
GENZYME CORPORATION
$178
ABBVIE INC.
$172
SOBI, INC
$154
Alexion Pharmaceuticals, Inc.
$153
Gilead Sciences, Inc.
$150
Incyte Corporation
$149
Bayer Healthcare Pharmaceuticals Inc.
$119
Amgen Inc.
$112
PharmaEssentia USA Corporation
$104
Blueprint Medicines Corporation
$94
Genentech USA, Inc.
$82
Genmab U.S., Inc.
$81
TerSera Therapeutics LLC
$74
Lilly USA, LLC
$72
BeiGene USA, Inc.
$60
SERVIER PHARMACEUTICALS LLC
$60
Astellas Pharma US Inc
$56
ADC Therapeutics America, Inc.
$54
Takeda Pharmaceuticals U.S.A., Inc.
$53
E.R. Squibb & Sons, L.L.C.
$51
SpringWorks Therapeutics, Inc.
$51
Menarini Silicon Biosystems, Inc.
$44
Mirati Therapeutics, Inc.
$43
JAZZ PHARMACEUTICALS INC.
$42
Rigel Pharmaceuticals, Inc.
$41
ARRAY BIOPHARMA INC
$39
Fennec Pharmaceuticals, Inc.
$34
Karyopharm Therapeutics Inc.
$27
Tempus AI, Inc
$25
Janssen Pharmaceuticals, Inc
$24
Exelixis Inc.
$24
Dendreon Pharmaceuticals LLC
$23
Agios Pharmaceuticals, Inc.
$23
Stemline Therapeutics Inc.
$23
GlaxoSmithKline, LLC.
$21
Pharmacosmos Therapeutics Inc.
$18
Regeneron Healthcare Solutions, Inc.
$17
Kyowa Kirin, Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$15
Top 3 companies account for 51.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$15,275
E.R. Squibb & Sons, L.L.C.
$5,751
PFIZER INC.
$4,476
ABBVIE INC.
$3,985
Lilly USA, LLC
$3,947
Ipsen Biopharmaceuticals, Inc
$2,436
Novartis Pharmaceuticals Corporation
$1,767
Bayer HealthCare Pharmaceuticals Inc.
$1,590
Celgene Corporation
$771
Incyte Corporation
$534
Eisai Inc.
$434
Merck Sharp & Dohme LLC
$406
Alexion Pharmaceuticals, Inc.
$314
Genentech USA, Inc.
$305
Janssen Biotech, Inc.
$281
Amgen Inc.
$265
Daiichi Sankyo Inc.
$251
Merck Sharp & Dohme Corporation
$244
Puma Biotechnology, Inc.
$240
Stemline Therapeutics Inc.
$217
Gilead Sciences, Inc.
$201
GENZYME CORPORATION
$199
Janssen Scientific Affairs, LLC
$181
SOBI, INC
$167
Regeneron Healthcare Solutions, Inc.
$164
Bayer Healthcare Pharmaceuticals Inc.
$144
Myovant Sciences Inc.
$144
Biocompatibles, Inc.
$121
Blueprint Medicines Corporation
$118
Novocure Inc.
$110
Takeda Pharmaceuticals U.S.A., Inc.
$110
Boston Scientific Corporation
$108
PharmaEssentia USA Corporation
$104
SERVIER PHARMACEUTICALS LLC
$95
AbbVie, Inc.
$94
Genmab U.S., Inc.
$81
Astellas Pharma US Inc
$78
TerSera Therapeutics LLC
$74
Pharmacosmos Therapeutics Inc.
$70
Seagen Inc.
$68
Epizyme, Inc.,
$64
BeiGene USA, Inc.
$60
JAZZ PHARMACEUTICALS INC.
$60
GlaxoSmithKline, LLC.
$55
ADC Therapeutics America, Inc.
$54
SpringWorks Therapeutics, Inc.
$51
G1 Therapeutics, Inc.
$46
Menarini Silicon Biosystems, Inc.
$44
Agios Pharmaceuticals, Inc.
$43
Mirati Therapeutics, Inc.
$43
Rigel Pharmaceuticals, Inc.
$41
ARRAY BIOPHARMA INC
$39
Fennec Pharmaceuticals, Inc.
$34
Janssen Pharmaceuticals, Inc
$33
Octapharma USA, Inc.
$33
Kite Pharma, Inc.
$33
EMD Serono, Inc.
$31
Karyopharm Therapeutics Inc.
$27
Sirtex Medical Inc
$26
Foundation Medicine, Inc.
$26
Tempus AI, Inc
$25
Exelixis Inc.
$24
Dendreon Pharmaceuticals LLC
$23
TAIHO ONCOLOGY, INC.
$23
MorphoSys, US Inc.
$20
Deciphera Pharmaceuticals Inc.
$16
Kyowa Kirin, Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$15
Adaptive Biotechnologies Corporation
$12
Top 3 companies account for 54.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · AYVAKIT · Alecensa · BAVENCIO · BESREMI · BOSULIF · BRUKINSA · Blincyto · CABOMETYX · COSELA · CUTAQUIG · Cellsearch · DARZALEX · DOPTELET · Doptelet · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EVENITY · Enhertu · Epkinly · Erleada · FRUZAQLA · Fabhalta · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · Jivi · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MONJUVI · MONOFERRIC · MYLOTARG · NINLARO · Nerlynx · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Phesgo · Polivy · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rituxan · SARCLISA · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · Stivarga · TAGRISSO · TAZVERIK · THERASPHERE - BIO · TIVDAK · Tazverik · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Tibsovo · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · Vanflyta · Venclexta · Vitrakvi · XARELTO · XPOVIO · XT CDX · XTANDI · Xtandi · Yescarta · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
44
County median income
$83,030
Nearest hospital to ZIP centroid (approximate)
OVIEDO MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Eldawy is a mixed practice specialist, with above-average Medicare volume (top 26% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Eldawy experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Eldawy performed 8,100 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Eldawy receive payments from pharmaceutical companies?
Yes. Dr. Eldawy received a total of $46,938 from 69 companies across 448 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eldawy's costs compare to other hematology & oncology specialists in Oviedo?
Dr. Eldawy's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eldawy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Oviedo
Browse hematology & oncology specialists in Oviedo ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology